House panel: Mylan CEO minimized EpiPen profits in testimony

Leaders of the House Oversight Committee want EpiPen maker Mylan to explain why the company’s CEO apparently misled Congress about profits the company claimed for the life-saving EpiPen injection device

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s